These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9932951)

  • 1. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
    Martin R; Kuzniecky R; Ho S; Hetherington H; Pan J; Sinclair K; Gilliam F; Faught E
    Neurology; 1999 Jan; 52(2):321-7. PubMed ID: 9932951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults.
    Kuzniecky R; Ho S; Pan J; Martin R; Gilliam F; Faught E; Hetherington H
    Neurology; 2002 Feb; 58(3):368-72. PubMed ID: 11839834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer anticonvulsants: lamotrigine, topiramate and gabapentin.
    Holmes LB; Hernandez-Diaz S
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):599-606. PubMed ID: 22730257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiepileptic drugs on cognition.
    Aldenkamp AP
    Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults.
    Martin R; Meador K; Turrentine L; Faught E; Sinclair K; Kuzniecky R; Gilliam F
    Epilepsia; 2001 Jun; 42(6):764-71. PubMed ID: 11422333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
    Lhatoo SD; Sander JW; Wong IC
    Neurology; 2000 Jan; 54(1):270-1; author reply 271-2. PubMed ID: 10636174
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive side effects of anticonvulsants.
    Goldberg JF; Burdick KE
    J Clin Psychiatry; 2001; 62 Suppl 14():27-33. PubMed ID: 11469672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
    Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
    Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the tolerability of the newer mood stabilizers.
    Alao AO; Dewan MJ
    J Nerv Ment Dis; 2001 Jan; 189(1):60-3. PubMed ID: 11206668
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical administration of new antiepileptic drugs: an overview of safety and efficacy.
    Chadwick DW; Marson T; Kadir Z
    Epilepsia; 1996; 37 Suppl 6():S17-22. PubMed ID: 8941038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
    Johannessen SI
    Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiepileptic drugs: comparison of key clinical trials.
    Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH
    Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
    Aldenkamp AP
    Neurology; 2000 Jan; 54(1):271-2. PubMed ID: 10636175
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin.
    Curry WJ; Kulling DL
    Am Fam Physician; 1998 Feb; 57(3):513-20. PubMed ID: 9475899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning.
    Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P
    Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers.
    Salinsky MC; Storzbach D; Spencer DC; Oken BS; Landry T; Dodrill CB
    Neurology; 2005 Mar; 64(5):792-8. PubMed ID: 15753411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.